Investors might want to bet on AN2 Therapeutics, Inc. (ANTX) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.S ...

HUTCHMED (HCM) closed the last trading session at $13.75, gaining 0.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $21.44 indicates a 55.9% upside potential.The average comprises four short-term price targets ranging from a low of $13.75 to a high of $32.00, with a standard deviation of $7.81. While the lowest estimate indicates no increase from the current price level, the mos ...

Flotek Industries (FTK) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual ...

Global-e Online Ltd. (GLBE) closed the last trading session at $38.4, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $48.85 indicates a 27.2% upside potential.The average comprises 13 short-term price targets ranging from a low of $41.00 to a high of $64.00, with a standard deviation of $5.58. While the lowest estimate indicates an increase of 6.8% from the current pr ...

Albertsons Companies, Inc. (ACI) closed the last trading session at $17.26, gaining 0.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $23.53 indicates a 36.3% upside potential.The mean estimate comprises 15 short-term price targets with a standard deviation of $2.72. While the lowest estimate of $19.00 indicates a 10.1% increase from the current price level, the most optimistic ...

Shares of Kyndryl Holdings, Inc. (KD) have gained 1.2% over the past four weeks to close the last trading session at $26.28, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $37.6 indicates a potential upside of 43.1%.The mean estimate comprises five short-term price targets with a standard deviation of $10.78. While the lowest estimate of $28.00 indicates a 6.5% increase from th ...

American Superconductor (AMSC) closed the last trading session at $33.21, gaining 2.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $62 indicates an 86.7% upside potential.The average comprises four short-term price targets ranging from a low of $52.00 to a high of $73.00, with a standard deviation of $10.1. While the lowest estimate indicates an increase of 56.6% from the curre ...

Investors might want to bet on Kezar Life Sciences, Inc. (KZR) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The ...

Photronics (PLAB) closed the last trading session at $33.41, gaining 38.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $43.23 indicates a 29.4% upside potential.The average comprises three short-term price targets ranging from a low of $42.00 to a high of $45.00, with a standard deviation of $1.57. While the lowest estimate indicates an increase of 25.7% from the current price ...

Nuvation Bio Inc. (NUVB) closed the last trading session at $8.58, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.33 indicates a 32.1% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $2.78. While the lowest estimate of $8.00 indicates a 6.8% decline from the current price level, the most optimistic analyst ex ...